 LivaNova PLC NASDAQ: LIVN posted Q3 sales of 253.2 million, 5.5 YY on a reported basis and 5 on a constant-currency basis, beating the consensus of 245.27 million. Excluding Heart Valves business, divested in June, sales increased by 15.7 on a reported basis and 15.2 on a constant currency. 